Core Viewpoint - The company, KeFu Medical (301087.SZ), is strategically investing in the brain-computer interface sector, enhancing its existing business and positioning itself for future technological integration and industry upgrades [1] Investment in Neuralink Medical - In May 2024, the company invested in Neuralink Medical, acquiring a 5.83% stake [1] - Neuralink Medical focuses on implantable brain-computer interface technology, particularly in developing bionic eye and ear products [1] - This investment aligns with the company's current hearing business, providing significant value in addressing congenital hearing loss [1] Investment in Lizi Intelligent - By the end of 2025, the company plans to invest in Lizi Intelligent, obtaining a 12.45% stake [1] - Lizi Intelligent is dedicated to the development of non-invasive brain-computer interface robots and other products [1] - This investment is expected to create strategic synergies with the company's rehabilitation aids and respiratory support products [1] Strategic Implications - The company's entry into the brain-computer interface field not only strengthens the synergy potential of its existing businesses but also lays the groundwork for future technological convergence and industry upgrades [1]
可孚医疗(301087.SZ)：目前公司在脑机接口领域已参与两项战略性投资